A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Clinical trial NCT04424641 · TERMINATED

Trial details

NCT number: NCT04424641
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumor(s)Prostate Cancer Esophageal Cancer Triple Negative Breast Cancer (TNBC)Squamous Cell Carcinoma of Head and Neck (SCCHN)Non-small Cell Lung Cancer (NSCLC)Bladder Cancer Uterine Cancer

Start date: 2020-07-15
Primary completion: 2021-10-29
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.